Pharmiva is an innovation driven company with a focus on diseases related to women’s health. We develop and market products based on a unique expert knowledge within research and development of medical products aimed for local administration.
Last update: 14 Dec 2020
| GÅL Pharma Consulting | 10,0% |
| Indavvio AB | 9,8% |
| Venture Holdings AB | 6,0% |
| Prolajm AB | 4,9% |
| Nordnet Pensionsförsäkring | 4,8% |
| Quantify AB | 4,3% |
| TPJA Holding AB | 3,3% |
| CBC Holding AB | 3,2% |
| CBC Womens Health | 3,1% |
| Universal Energy AB | 2,4% |
| John Moll | 2,1% |
| Other investors (external shareholders) | 46,1% |